Skip to content

To explore the therapeutic effect and mechanism of moxibustion on functional constipation based on intestinal flora

To explore the therapeutic effect and mechanism of moxibustion on functional constipation based on intestinal flora

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077683
Enrollment
Unknown
Registered
2023-11-16
Start date
2023-11-30
Completion date
Unknown
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation

Interventions

Treatment group:Lactulose+moxibustion
control group:Lactulose+comfort moxibustion

Sponsors

General Hospital of the Western Theater of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ? Meets the diagnostic criteria of Western medicine for functional constipation; ? Qi deficiency constipation patients; ? Between the ages of 18 and 70; ? Excluding constipation secondary to organic diseases; ? The subject must have informed consent and voluntarily accept and cooperate with this trial treatment plan; ? The subjects have the ability to make independent judgments and express themselves in language; ? Subject can lie on their side for a long time (>30 minutes)

Exclusion criteria

Exclusion criteria: ? Those who do not meet the inclusion criteria mentioned above; ? Those with severe diseases of important organs such as the heart, brain, lungs, liver, and kidneys; ? Individuals who have taken traditional Chinese medicine, Western medicine, and probiotics for the treatment of this disease within one month prior to inclusion in the trial; ? Participants in other clinical trials within one month prior to inclusion in the trial; ? Patients with severe skin diseases; ? Those who are prohibited from using lactulose oral liquid; ? Diarrhea confirmed through investigation to be caused by infectious diarrhea, inflammatory bowel disease, hyperthyroidism, malignant tumors, and other diseases; ? Pregnant or lactating patients

Design outcomes

Primary

MeasureTime frame
Intestinal flora;Score of bowel movements;Bristol score;

Secondary

MeasureTime frame
Quality of life scale (PAC-QOL) score of constipation patients;SDS score;SAS score;Symptom Checklist Score for Constipation Patients (PAC-SYM Score);

Countries

China

Contacts

Public ContactPang Rizhao

General Hospital of the Western Theater of the Chinese People's Liberation Army

przprz17@126.com+86 189 8002 0187

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026